Dublin, June 03, 2020 (GLOBE NEWSWIRE) -- The "Night Vision Disturbances Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of NVDs in the United States. The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Night Vision Disturbances (NVD) from 2017 to 2028 in the United States. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
The report includes details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Night Vision Disturbances in the US, Europe and Japan.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Incident Cases of NVD in the United States, Incident cases of NVD by Type of Surgeries, Incidence of NVD Manifestations) scenario of Night Vision Disturbances (NVD)in the United States from 2017 - 2028.
According to this research, the total number of Incident cases of Night Vision Disturbances (NVD) in 7 MM was found to be 3,392,937 in the year 2017.
Night Vision Disturbances Report Insights
- Patient Population
- Therapeutic Approaches
- Pipeline Analysis
- Market Size and Trends
- Market Opportunities
- Impact of upcoming Therapies
Night Vision Disturbances Report Key Strengths
- 10 Years Forecast
- The United States Coverage
- Epidemiology Segmentation
- Key Cross Competition
- Market Size by Therapies
- Drugs Uptake
Night Vision Disturbances Report Assessment
- Pipeline Product Profiles
- Key Products and Key Players
- Market Drivers and Barriers
Key Topics Covered:
1. Key Insights
2. Disease Background and Overview
2.1. Introduction
2.2. Types of NVD
2.3. Causes and Risk Factors
2.4. Etiology of NVD
2.5. Symptoms
2.6. Diagnosis
3. Epidemiology and Patient Population
3.1. Key Findings
3.2. Assumptions and Rationale
3.3. Total Incident Cases of NVD in the United States
3.4. Incident cases of NVD by Type of Surgeries in the United States
3.5. Incidence of NVD Manifestations in the United States
4. Treatment
5. Unmet needs
6. Emerging Drugs
6.1. Nyxol: Ocuphire Pharma
6.1.1. Product Description
6.1.2. Product Development Activities
6.1.3. Clinical development
6.1.3.1. Clinical Trials Information
6.2. Safety and Efficacy
6.3. Product Profile
7. Night Vision Disturbances (NVD): The United States Market
7.1. Market Outlook
7.2. Key Findings
7.3. Market Size of NVD in the United States
7.4. Market Size of NVD by Therapies
8. Market Barriers
9. Market Drivers
10. Appendix
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/nuq6mv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900